Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinoma.
about
Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinoma.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Validation of the SNACOR clini ...... with hepatocellular carcinoma.
@en
Validation of the SNACOR clini ...... with hepatocellular carcinoma.
@nl
type
label
Validation of the SNACOR clini ...... with hepatocellular carcinoma.
@en
Validation of the SNACOR clini ...... with hepatocellular carcinoma.
@nl
prefLabel
Validation of the SNACOR clini ...... with hepatocellular carcinoma.
@en
Validation of the SNACOR clini ...... with hepatocellular carcinoma.
@nl
P2093
P2860
P50
P1433
P1476
Validation of the SNACOR clini ...... with hepatocellular carcinoma.
@en
P2093
Aline Mähringer-Kunz
Arndt Weinmann
Christoph Dueber
Irene Schmidtmann
Peter Robert Galle
Sandra Koch
Sebastian Schotten
P2860
P2888
P356
10.1186/S12885-018-4407-5
P407
P577
2018-04-27T00:00:00Z
P6179
1103672090